These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24723343)

  • 21. Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.
    Kontostathi G; Zoidakis J; Makridakis M; Lygirou V; Mermelekas G; Papadopoulos T; Vougas K; Vlamis-Gardikas A; Drakakis P; Loutradis D; Vlahou A; Anagnou NP; Pappa KI
    Biomed Res Int; 2017; 2017():4180703. PubMed ID: 28261610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
    Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
    J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High glucose-induced proteome alterations in hepatocytes and its possible relevance to diabetic liver disease.
    Chen JY; Chou HC; Chen YH; Chan HL
    J Nutr Biochem; 2013 Nov; 24(11):1889-910. PubMed ID: 24011924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
    Guidi F; Puglia M; Gabbiani C; Landini I; Gamberi T; Fregona D; Cinellu MA; Nobili S; Mini E; Bini L; Modesti PA; Modesti A; Messori L
    Mol Biosyst; 2012 Apr; 8(4):985-93. PubMed ID: 22134777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
    Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
    Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.
    Zhu H; Pei HP; Zeng S; Chen J; Shen LF; Zhong MZ; Yao RJ; Shen H
    J Proteome Res; 2009 Aug; 8(8):3969-76. PubMed ID: 19507834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
    Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
    J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox-proteomic analysis of doxorubicin resistance-induced altered thiol activity in uterine carcinoma.
    Lin ST; Lo YW; Chang SJ; Wang WC; Chang MD; Lyu PC; Chen YW; Chou HC; Chan HL
    J Pharm Biomed Anal; 2013 May; 78-79():1-8. PubMed ID: 23425445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma.
    Lee YR; Chen YW; Tsai MC; Chou HC; Chan HL
    Mol Biosyst; 2012 Oct; 8(12):3314-24. PubMed ID: 23090237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic analysis of human small cell lung cancer tissues: up-regulation of coactosin-like protein-1.
    Jeong HC; Kim GI; Cho SH; Lee KH; Ko JJ; Yang JH; Chung KH
    J Proteome Res; 2011 Jan; 10(1):269-76. PubMed ID: 21047053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
    Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
    Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.
    Hu S; Yu T; Xie Y; Yang Y; Li Y; Zhou X; Tsung S; Loo RR; Loo JR; Wong DT
    Cancer Genomics Proteomics; 2007; 4(2):55-64. PubMed ID: 17804867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
    Melle C; Ernst G; Schimmel B; Bleul A; Kaufmann R; Hommann M; Richter KK; Daffner W; Settmacher U; Claussen U; von Eggeling F
    J Proteome Res; 2005; 4(5):1799-804. PubMed ID: 16212435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
    Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
    Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
    Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
    Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.